3/31/2016 | CV | Acquisition of Affymetrix a make-whole change under 4% convertibles
|
9/5/2013 | CV | Market Commentary: Cubist's two new tranches add on debut; Liberty exchangeable softens; Affymetrix slips
|
9/4/2013 | CV | Market Commentary: New Liberty exchangeable expands on hedge; Cubist upsizes, tightens talk; Navistar slips
|
8/1/2013 | CV | Market Commentary: ViroPharma convertibles add on hedge; Trinity contracts; ArcelorMittal mandatories flat
|
12/3/2012 | CVLM | Affymetrix calls remaining $3.9 million of 3.5% convertible notes
|
6/20/2012 | CV | Market Commentary: New Affymetrix mixed; Navistar unmoved by poison pill; L-3, United Technologies better
|
6/20/2012 | CV | New Issue: Affymetrix prices $105 million seven-year convertibles at 4%, up 25%
|
6/19/2012 | CV | Affymetrix's $105 million seven-year convertibles see revised talk of 3.75%-4% coupon, up 25%
|
6/19/2012 | CV | Market Commentary: Revised price talk makes planned Affymetrix cheaper; DryShips expands; K-V Pharma drops
|
6/18/2012 | CV | Affymetrix plans $105 million seven-year convertibles to yield 3.25%-3.75%, up 27.5%-32.5%
|
6/18/2012 | CV | Market Commentary: Affymetrix to price $105 million convertibles; Royal Gold extends gains; InterDigital adds
|
5/31/2012 | CVHYPF | Affymetrix files $200 million shelf covering debt, preferreds, stock
|
3/6/2012 | CVLM | Affymetrix settles tenders for 96% of its 3.5% convertibles in offer
|
2/3/2012 | CVLM | Affymetrix begins tender offer for $95.47 million 3.5% convertibles
|
1/25/2012 | CVLM | Affymetrix to tender for $95.5 million 3.5% convertibles in settlement
|
12/30/2011 | CV | Affymetrix convertibles holder sues over eBioscience acquisition
|
1/12/2011 | CVLM | Affymetrix buys back additional $53 million 3.5% convertible notes
|
10/27/2010 | CVLM | Affymetrix buys back $72 million 3.5% convertibles for $66.9 million
|
7/21/2010 | CVLM | Affymetrix repurchases $95.8 million of 3.5% convertibles at discount
|
7/7/2010 | CV | Market Commentary: FTI Consulting richens despite revised outlook; Affymetrix steady; EMC gains after upgrade
|
5/29/2009 | CV | Affymetrix buys back $69.1 million in 3.5% convertible notes due 2038
|
7/25/2008 | CV | Market Commentary: Affymetrix down on quarterly loss; Amgen steady pre-earnings; Countrywide bondholders eye angles
|
12/13/2007 | CV | Affymetrix greenshoe lifts 3.5% convertibles due 2038 to $316.25 million
|
11/15/2007 | CV | Market Commentary: Avery Dennison opens higher; Freeport-McMoRan, Newmont give back gains; Countrywide, Fannie Mae plunge
|
11/14/2007 | CV | New Issue: Affymetrix prices upsized $275 million 3.5% convertibles, up 39%
|
11/14/2007 | CV | Market Commentary: Affymetrix, Mylan rich and up; Freeport-McMoRan, Newmont up with metals; AMR mixed
|
11/13/2007 | CV | Affymetrix prices upsized $275 million convertibles at 3.5%, up 39%
|
11/13/2007 | CV | Market Commentary: E*Trade rebounds; Countrywide Financial up; AMR continues to fly; Yahoo!, Intel lead techs
|
7/25/2007 | CV | Convertible analyst Berkman identifies safe harbors in choppy market seas
|
8/30/2006 | BTCVDD | Affymetrix cures default on 0.75% convertibles with filing of restated financials
|
8/28/2006 | BTCVDD | Affymetrix receives default notice on 0.75% convertibles for failure to file 10-Q
|
1/6/2006 | CV | Market Commentary: Convertibles market moves mostly in-line, dollar neutral; Best Buy, Cephalon gain; Affymetrix drops
|
5/20/2004 | CV | Market Commentary: Airline paper cheapens further, despite rise in stocks; Guilford shelf uplifts holders of rich bonds
|
1/20/2004 | CV | Affymetrix to redeem 43/4% convertibles
|
12/10/2003 | CV | Affymetrix sells $100 million convertible at 0.75%, up 28%
|
12/10/2003 | CV | Affymetrix calls 5% convertibles
|
12/9/2003 | CV | Market Commentary: Another $2.575 billion of deals; Akamai, Emulex both reoffered at 98
|
12/9/2003 | CV | Affymetrix $100 million convertible talked at 0.5-1.0%, up 23-28%
|
12/8/2003 | CV | Affymetrix plans $100 million convertible to redeem old issues
|
12/8/2003 | CV | Market Commentary: Issuers unwrap $1.73 billion of new paper and more set to come this week, this month
|
4/4/2003 | CV | Market Commentary: Yahoo! overnighter meets few cheers; AES plan lifts power group; warning crushes Affymetrix
|
3/31/2003 | CV | Millennium may add sweetener to discourage exercise of upcoming put
|
1/30/2003 | CV | Market Commentary: Micron trading lighter as outright buyers hold on; several drug issues gain
|
7/10/2002 | CV | Market Commentary: Stock plunge, earnings worries sideline players, pressure prices
|